The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry

In patients with myelodysplastic syndrome (MDS), the prognostic significance of chromosome 17 abnormalities has not yet been fully elucidated, except for isochromosome 17q that has been characterized as an intermediate risk abnormality in the Revised International Prognostic Scoring System (IPSS‐R)....

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Cancer Med
Główni autorzy: Diamantopoulos, Panagiotis, Koumbi, Dafni, Kotsianidis, Ioannis, Pappa, Vasiliki, Symeonidis, Argiris, Galanopoulos, Athanasios, Zikos, Panagiotis, Papadaki, Helen A., Panayiotidis, Panayiotis, Dimou, Maria, Hatzimichael, Eleftheria, Vassilopoulos, George, Delimpasis, Susan, Mparmparousi, Despoina, Papageorgiou, Sotirios, Variami, Eleni, Kyrtsonis, Marie‐Christine, Megalakaki, Aekaterini, Kotsopoulou, Maria, Repousis, Panagiotis, Adamopoulos, Ioannis, Kontopidou, Flora, Christoulas, Dimitrios, Kourakli, Alexandra, Tsokanas, Dimitrios, Konstantinos Papoutselis, Menelaos, Kyriakakis, Georgios, Viniou, Nora‐Athina
Format: Artigo
Język:Inglês
Wydane: John Wiley and Sons Inc. 2019
Hasła przedmiotowe:
Clinical Cancer Research
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536924/
https://ncbi.nlm.nih.gov/pubmed/30897290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2090
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy